ClinicalThought

Share

Program Content

Activities

  • Pancreatic PARP Inhibitors
    My Perspective on the Use of PARP Inhibition in Pancreatic Cancer Treatment
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 30, 2020

    Expires: October 29, 2021

Faculty

cover img faculity

Dirk Arnold, MD, PhD

Director
Asklepios Tumorzentrum Hamburg
Department of Oncology
AK Altona
Hamburg, Germany

Supporters

AstraZeneca